Stocks News

LAST PRICE
57.7300
TODAY'S CHANGE (%)
Trending Down-2.7600 (-4.5627%)

Bid / Lots
56.6800/ 1
Ask / Lots
58.8800/ 1
Open / Previous Close
60.1400 / 60.4900
Day Range
Low 57.6800
High 60.3100
52 Week Range
Low 54.5501
High 94.8600
Volume
1,077,386
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 8, 2024
- Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones
  7:00AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: BRKR
  
  Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
  
  New Technology Expands Antibody Compatibility and Doubles Throughput while maintaining Tissue Integrity and Lack of Cross-Reactivity
Nov 6, 2024
- DJ Bruker Is Maintained at Buy by Citigroup, from 2:08PM ET on Wednesday Nov 06, 2024 by Dow Jones
  2:08PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: BRKR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BRKR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 06, 2024 14:08 ET (19:08 GMT)
- DJ Bruker Is Maintained at Hold by TD Cowen, from 12:54PM ET on Wednesday Nov 06, 2024 by Dow Jones
  12:54PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: BRKR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BRKR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 06, 2024 12:54 ET (17:54 GMT)
- DJ Bruker Is Maintained at Overweight by Wells Fargo, from 10:40AM ET on Wednesday Nov 06, 2024 by Dow Jones
  10:40AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: BRKR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BRKR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 06, 2024 10:40 ET (15:40 GMT)
- DJ Bruker Is Maintained at Overweight by Barclays, from 9:25AM ET on Wednesday Nov 06, 2024 by Dow Jones
  9:25AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: BRKR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BRKR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 06, 2024 09:25 ET (14:25 GMT)

Nov 8, 2024
- Sector Update: Health Care Stocks Advance Late Afternoon, from 3:56PM ET on Friday Nov 08, 2024 by MT Newswires
  3:56PM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: ASTH, MRVI, ARDX, EVH
- Sector Update: Health Care, from 3:37PM ET on Friday Nov 08, 2024 by MT Newswires
  3:37PM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: EVH
- Top Midday Decliners, from 2:14PM ET on Friday Nov 08, 2024 by MT Newswires
  2:14PM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: PRPH, MRVI, EVH
- Sector Update: Health Care Stocks Rise in Afternoon Trading, from 1:58PM ET on Friday Nov 08, 2024 by MT Newswires
  1:58PM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: QDEL, ASTH, AGL
- QuidelOrtho Shares Jump After Q3 Beat; Philip McLellan Named COO, from 12:35PM ET on Friday Nov 08, 2024 by MT Newswires
  12:35PM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: QDEL
- DJ QuidelOrtho Up Over 14%, on Pace for Largest Percent Increase Since June 2020 -- Data Talk, from 11:57AM ET on Friday Nov 08, 2024 by Dow Jones
  11:57AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: QDEL
- Oppenheimer Adjusts Evolent Health Price Target to $34 From $45, Maintains Outperform Rating, from 11:41AM ET on Friday Nov 08, 2024 by MT Newswires
  11:41AM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: EVH
- UBS Cuts Price Target on QuidelOrtho to $43 From $50, Maintains Neutral Rating, from 11:39AM ET on Friday Nov 08, 2024 by MT Newswires
  11:39AM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: QDEL
- DJ Evolent Health Is Maintained at Outperform by Oppenheimer, from 11:21AM ET on Friday Nov 08, 2024 by Dow Jones
  11:21AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: EVH
- RBC Capital Adjusts QuidelOrtho Price Target to $64 From $62, Maintains Outperform Rating, from 10:53AM ET on Friday Nov 08, 2024 by MT Newswires
  10:53AM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: QDEL

Bruker Corp
NASDAQ:BRKRUnited States

Search Criteria

Nov 8, 2024

Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 6, 2024

DJ Bruker Is Maintained at Buy by Citigroup, from 2:08PM ET on Wednesday Nov 06, 2024 by Dow Jones

DJ Bruker Is Maintained at Hold by TD Cowen, from 12:54PM ET on Wednesday Nov 06, 2024 by Dow Jones

DJ Bruker Is Maintained at Overweight by Wells Fargo, from 10:40AM ET on Wednesday Nov 06, 2024 by Dow Jones

DJ Bruker Is Maintained at Overweight by Barclays, from 9:25AM ET on Wednesday Nov 06, 2024 by Dow Jones

Peers Headlines

Nov 8, 2024

Sector Update: Health Care Stocks Advance Late Afternoon, from 3:56PM ET on Friday Nov 08, 2024 by MT Newswires

Sector Update: Health Care, from 3:37PM ET on Friday Nov 08, 2024 by MT Newswires

Top Midday Decliners, from 2:14PM ET on Friday Nov 08, 2024 by MT Newswires

Sector Update: Health Care Stocks Rise in Afternoon Trading, from 1:58PM ET on Friday Nov 08, 2024 by MT Newswires

QuidelOrtho Shares Jump After Q3 Beat; Philip McLellan Named COO, from 12:35PM ET on Friday Nov 08, 2024 by MT Newswires

DJ QuidelOrtho Up Over 14%, on Pace for Largest Percent Increase Since June 2020 -- Data Talk, from 11:57AM ET on Friday Nov 08, 2024 by Dow Jones

Oppenheimer Adjusts Evolent Health Price Target to $34 From $45, Maintains Outperform Rating, from 11:41AM ET on Friday Nov 08, 2024 by MT Newswires

UBS Cuts Price Target on QuidelOrtho to $43 From $50, Maintains Neutral Rating, from 11:39AM ET on Friday Nov 08, 2024 by MT Newswires

DJ Evolent Health Is Maintained at Outperform by Oppenheimer, from 11:21AM ET on Friday Nov 08, 2024 by Dow Jones

RBC Capital Adjusts QuidelOrtho Price Target to $64 From $62, Maintains Outperform Rating, from 10:53AM ET on Friday Nov 08, 2024 by MT Newswires